8-K Announcements
6Material company update
May 20, 2026·SEC
Material company update
May 14, 2026·SEC
Material company update
Apr 23, 2026·SEC
SBC Medical Group Holdings Incorporated(SBC)Earnings, Financials & Key Ratios
SBC•NASDAQ
6.1× P/E·Price updated Jun 19, 2026
AboutSBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.Show more
- Revenue$174M-15.5%
- EBITDA$70M-5.3%
- Net Income$51M+9.4%
- EPS (Diluted)0.50+4.2%
- Gross Margin73.32%-3.5%
- EBITDA Margin40.42%+12.0%
- Operating Margin38.87%+13.6%
- Net Margin29.37%+29.4%
- ROE22.25%-19.1%
SBC Key Insights
SBC Medical Group Holdings Incorporated (SBC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 27.0%
- ✓FCF machine: 21.1% free cash flow margin
- ✓Healthy 5Y average net margin of 19.0%
- ✓Trading at only 1.2x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Weak momentum: RS Rating 15 (bottom 15%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SBC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SBC Price & Volume
SBC Medical Group Holdings Incorporated (SBC) stock price & volume — 10-year historical chart
Loading chart...
SBC Growth Metrics
SBC Medical Group Holdings Incorporated (SBC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-0.11%
TTM-14.45%
Profit CAGR
10 Years-
5 Years-
3 Years100.61%
TTM-17.36%
EPS CAGR
10 Years-
5 Years-
3 Years99.79%
TTM-21.77%
Return on Capital
10 Years32.11%
5 Years32.11%
3 Years37.42%
Last Year25.75%
SBC Recent Earnings
SBC Medical Group Holdings Incorporated (SBC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (57%)●Beat Revenue 2/12 qtrs (29%)
Q2 2026Latest
May 14, 2026Metric
Actual
Est
EPS
$0.11+10.0%
$0.10
Rev
$43M+3.4%
$42M
Q2 2026
Mar 27, 2026Metric
Actual
Est
EPS
$0.14+7.7%
$0.13
Rev
$40M-12.9%
$45M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.12-7.7%
$0.13
Rev
$43M-4.1%
$45M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.02-85.7%
$0.14
Rev
$43M-5.0%
$46M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.11vs $0.10+10.0% | $43Mvs $42M+3.4% |
| Q2 2026 | Mar 27, 2026 | $0.14vs $0.13+7.7% | $40Mvs $45M-12.9% |
| Q4 2025 | Nov 14, 2025 | $0.12vs $0.13-7.7% | $43Mvs $45M-4.1% |
| Q3 2025 | Aug 13, 2025 | $0.02vs $0.14-85.7% | $43Mvs $46M-5.0% |
Based on last 12 quarters of dataView full earnings history →
SBC Peer Comparison
SBC Medical Group Holdings Incorporated (SBC) competitors in Operations and human capital consulting — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SKIN | 85.9M | 0.66 | -4.14 | -10.02% | -2.03% | -9.41% | 6.20 | |
 INMD | 849.01M | 13.40 | 9.37 | -6.16% | 23.27% | 13.28% | 0.02 | |
 SSKN | 806.68K | 0.14 | -0.10 | -8.54% | -21.13% | -360.33% | 5.59 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 LASE | 39.74M | 2.32 | -2.27 | 131.96% | -268.71% | -44.07% | ||
 AEYE | 78.83M | 6.31 | -25.24 | 14.52% | -9.05% | -70.95% | 2.75 | |
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 EW | 50.37B | 87.36 | 47.74 | 11.55% | 17.64% | 10.35% | 0.07 |
Compare SBC vs Peers
SBC Medical Group Holdings Incorporated (SBC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SBC Income Statement
SBC Medical Group Holdings Incorporated (SBC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
Sales/Revenue | 174.16M | 193.54M | 205.42M | 173.61M | 169.34M |
Revenue Growth % | - | 11.13% | 6.13% | -15.48% | -14.45% |
Cost of Goods Sold | 59.33M | 56.24M | 49.37M | 46.32M | 50.46M |
COGS % of Revenue | 34.06% | 29.06% | 24.03% | 26.68% | - |
Gross Profit | 114.83M▲ 0% | 137.3M▲ 19.6% | 156.05M▲ 13.7% | 127.28M▼ 18.4% | 118.88M▲ 0% |
Gross Margin % | 65.94% | 70.94% | 75.97% | 73.32% | 70.2% |
Gross Profit Growth % | - | 19.57% | 13.65% | -18.43% | - |
Operating Expenses | 94.72M | 66.64M | 85.75M | 59.8M | 57.87M |
OpEx % of Revenue | 54.38% | 34.43% | 41.74% | 34.44% | - |
Selling, General & Admin | 93.48M | 66.23M | 70.09M | 59.8M | 59.29M |
SG&A % of Revenue | 53.68% | 34.22% | 34.12% | 34.44% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - |
Other Operating Expenses | 1.23M | 409.03K | 15.66M | 0 | 70.77K |
Operating Income | 20.12M▲ 0% | 70.66M▲ 251.2% | 70.3M▼ 0.5% | 67.49M▼ 4.0% | 61M▲ 0% |
Operating Margin % | 11.55% | 36.51% | 34.23% | 38.87% | 36.02% |
Operating Income Growth % | - | 251.24% | -0.5% | -4.01% | - |
EBITDA | 26.05M | 82.91M | 74.1M | 70.17M | 63.7M |
EBITDA Margin % | 14.96% | 42.84% | 36.07% | 40.42% | 37.62% |
EBITDA Growth % | - | 218.27% | -10.62% | -5.31% | -13.28% |
D&A (Non-Cash Add-back) | 5.93M | 12.25M | 3.8M | 2.68M | 2.69M |
EBIT | 23.71M | 73.62M | 73.48M | 82.23M | 68.49M |
Net Interest Income | 440.94K | 41.46K | -8.36K | 37.73K | -4.55K |
Interest Income | 472.38K | 86.75K | 19.94K | 198.31K | 264.63K |
Interest Expense | 31.44K | 45.29K | 28.3K | 160.58K | 269.18K |
Other Income/Expense | 3.56M | 2.92M | 3.15M | 14.58M | 8.47M |
Pretax Income | 23.68M▲ 0% | 73.58M▲ 210.8% | 73.46M▼ 0.2% | 82.07M▲ 11.7% | 69.47M▲ 0% |
Pretax Margin % | 13.59% | 38.02% | 35.76% | 47.27% | 41.02% |
Income Tax | 18.12M | 35.02M | 26.77M | 31.02M | 28.59M |
Effective Tax Rate % | 76.55% | 47.59% | 36.44% | 37.8% | 41.15% |
Net Income | 6.32M▲ 0% | 39.37M▲ 523.4% | 46.61M▲ 18.4% | 50.99M▲ 9.4% | 40.79M▲ 0% |
Net Margin % | 3.63% | 20.34% | 22.69% | 29.37% | 24.09% |
Net Income Growth % | - | 523.44% | 18.4% | 9.38% | -17.36% |
Net Income (Continuing) | 5.55M | 38.56M | 46.69M | 51.05M | 40.88M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 2.6M | 1.65M | -87K | 15.02M | 15.04M |
EPS (Diluted) | 0.06▲ 0% | 0.42▲ 569.9% | 0.48▲ 14.3% | 0.50▲ 4.2% | 0.40▲ 0% |
EPS Growth % | - | 569.86% | 14.29% | 4.17% | -21.77% |
EPS (Basic) | 0.06 | 0.42 | 0.48 | 0.50 | - |
Diluted Shares Outstanding | 15.07M | 94.19M | 96.56M | 103M | 102.58M |
Basic Shares Outstanding | 15.07M | 94.19M | 96.56M | 103M | 102.58M |
Dividend Payout Ratio | - | - | - | - | - |
SBC Balance Sheet
SBC Medical Group Holdings Incorporated (SBC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
Total Current Assets | 112.95M | 165.91M | 184.45M | 231.22M | 238.78M |
Cash & Short-Term Investments | 53.64M | 103.02M | 125.04M | 164.09M | 167.31M |
Cash Only | 51.74M | 103.02M | 125.04M | 163.77M | 167.31M |
Short-Term Investments | 1.91M | 0 | 0 | 319.19K | 0 |
Accounts Receivable | 43.65M | 53.13M | 48.19M | 52.61M | 13.09M |
Days Sales Outstanding | 91.47 | 100.2 | 85.63 | 110.62 | 120.03 |
Inventory | 1.35M | 3.09M | 1.49M | 2.79M | 2.32M |
Days Inventory Outstanding | 8.31 | 20.06 | 11.05 | 22 | 15.37 |
Other Current Assets | 37.23K | 162.12K | 25.54K | 11.72M | 56.06M |
Total Non-Current Assets | 112.53M | 92.9M | 81.63M | 149.22M | 149.24M |
Property, Plant & Equipment | 21.51M | 19.5M | 14.04M | 16.36M | 18.76M |
Fixed Asset Turnover | 8.10x | 9.92x | 14.63x | 10.61x | 11.17x |
Goodwill | 3.87M | 3.59M | 4.61M | 15.43M | 15.4M |
Intangible Assets | 7.27M | 19.74M | 1.59M | 47.74M | 47.15M |
Long-Term Investments | 916.03K | 20.66M | 20.87M | 58.02M | 105.67M |
Other Non-Current Assets | 73.7M | 29.41M | 30.72M | 7.66M | 61.75M |
Total Assets | 225.48M▲ 0% | 258.81M▲ 14.8% | 266.08M▲ 2.8% | 380.45M▲ 43.0% | 388.02M▲ 0% |
Asset Turnover | 0.77x | 0.75x | 0.77x | 0.46x | 0.48x |
Asset Growth % | - | 14.78% | 2.81% | 42.98% | 111.24% |
Total Current Liabilities | 101.25M | 92.45M | 61.19M | 61.12M | 62.57M |
Accounts Payable | 15.32M | 26.53M | 14.53M | 17.64M | 19.17M |
Days Payables Outstanding | 94.26 | 172.2 | 107.46 | 138.99 | 138.23 |
Short-Term Debt | 4.76M | 3.53M | 123.08K | 13.65M | 14.63M |
Deferred Revenue (Current) | 30.44M | 25.13M | 12.56M | 9.47M | 21.32M |
Other Current Liabilities | 25.2M | 832.52K | 227.89K | 11.54M | 27.76M |
Current Ratio | 1.12x | 1.79x | 3.01x | 3.78x | 3.82x |
Quick Ratio | 1.10x | 1.76x | 2.99x | 3.74x | 3.78x |
Cash Conversion Cycle | 5.52 | -51.94 | -10.78 | -6.37 | -2.84 |
Total Non-Current Liabilities | 16.38M | 22.54M | 9.87M | 56.02M | 55.07M |
Long-Term Debt | 5.53M | 13.01M | 6.51M | 33.73M | 5.83M |
Capital Lease Obligations | 2.36M | 2.44M | 1.24M | 4.25M | 7.33M |
Deferred Tax Liabilities | 7.34M | 6.01M | 926.02K | 16.37M | 40.71M |
Other Non-Current Liabilities | 1.15M | 1.07M | 1.19M | 1.66M | 33.03M |
Total Liabilities | 117.63M | 115M | 71.06M | 117.14M | 117.64M |
Total Debt | 16.13M | 22.87M | 12.21M | 51.64M | 20.45M |
Net Debt | -35.61M | -80.16M | -112.83M | -112.14M | -146.85M |
Debt / Equity | 0.15x | 0.16x | 0.06x | 0.20x | 0.08x |
Debt / EBITDA | 0.62x | 0.28x | 0.16x | 0.74x | 0.32x |
Net Debt / EBITDA | -1.37x | -0.97x | -1.52x | -1.60x | -2.31x |
Interest Coverage | 754.05x | 1625.55x | 2596.61x | 512.05x | 254.43x |
Total Equity | 107.85M▲ 0% | 143.81M▲ 33.3% | 195.02M▲ 35.6% | 263.3M▲ 35.0% | 270.38M▲ 0% |
Equity Growth % | - | 33.34% | 35.61% | 35.01% | 127.46% |
Book Value per Share | 7.16 | 1.53 | 2.02 | 2.56 | 2.64 |
Total Shareholders' Equity | 105.25M | 142.16M | 195.11M | 248.28M | 255.34M |
Common Stock | 0 | 9.42K | 10.3K | 10.39K | 10.39K |
Retained Earnings | 103.48M | 142.85M | 189.46M | 240.45M | 251.76M |
Treasury Stock | 0 | 0 | -2.7M | -7.75M | 0 |
Accumulated OCI | -24.85M | -37.58M | -54.18M | -57.29M | -61.54M |
Minority Interest | 2.6M | 1.65M | -87K | 15.02M | 15.04M |
SBC Cash Flow Statement
SBC Medical Group Holdings Incorporated (SBC) cash flow — operating, investing & free cash flow history
| Metric | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
Cash from Operations | -47.37K | 50.64M | 20.58M | 38.92M | 46.22M |
Operating CF Margin % | -0.03% | 26.17% | 10.02% | 22.42% | - |
Operating CF Growth % | - | 107012.84% | -59.36% | 89.09% | 725.16% |
Net Income | 5.55M | 39.37M | 46.61M | 50.99M | 40.79M |
Depreciation & Amortization | 5.93M | 12.25M | 3.8M | 2.68M | 2.7M |
Stock-Based Compensation | 0 | 0 | 13.02M | 0 | 0 |
Deferred Taxes | -3.9M | 4.11M | -14.42M | 5.33M | -4.43M |
Other Non-Cash Items | 2.96M | 2.59M | -16.31M | -7.79M | 3M |
Working Capital Changes | -10.59M | -7.68M | -12.13M | -12.28M | 4.17M |
Change in Receivables | -9.6M | -6.01M | 13.1M | 4.47M | -727.39K |
Change in Inventory | -666.64K | -1.83M | 1.12M | -170.17K | 396.75K |
Change in Payables | 172.61K | 12.2M | -8.91M | 2.67M | 1.36M |
Cash from Investing | -32.65M | 1.82M | -10.1M | -20.97M | -20.52M |
Capital Expenditures | -24.95M | -9.52M | -3.41M | -2.79M | -2.59M |
CapEx % of Revenue | 14.32% | 4.92% | 1.66% | 1.61% | 1.53% |
Acquisitions | -6.49M | 722.55K | -5.07M | -15.46M | -16.81M |
Investments | - | - | - | - | - |
Other Investing | 1.43M | 8.6M | -1.29M | 18.34M | 19.3M |
Cash from Financing | -7.98M | 6.14M | 22.97M | 24.04M | 22.48M |
Debt Issued (Net) | -5.08M | 3.58M | 6.48M | 18.83M | 17.04M |
Equity Issued (Net) | 118.82M | 10 | 31.37K | -5M | -5M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | -5M | -5M |
Other Financing | -121.72M | 2.56M | 16.45M | 10.21M | 10.44M |
Net Change in Cash | -52.77M▲ 0% | 51.28M▲ 197.2% | 22.02M▼ 57.1% | 38.73M▲ 75.9% | 35.25M▲ 0% |
Free Cash Flow | -24.99M▲ 0% | 39.44M▲ 257.8% | 17.17M▼ 56.4% | 36.55M▲ 112.8% | 44.06M▲ 0% |
FCF Margin % | -14.35% | 20.38% | 8.36% | 21.05% | 26.02% |
FCF Growth % | - | 257.79% | -56.45% | 112.82% | 186.7% |
FCF per Share | -1.66 | 0.42 | 0.18 | 0.35 | 0.43 |
FCF Conversion (FCF/Net Income) | -0.01x | 1.29x | 0.44x | 0.76x | 1.08x |
Interest Paid | 31.44K | 45.29K | 28.3K | 0 | 98.29K |
Taxes Paid | 30.82M | 17.84M | 30.24M | 0 | 16.98M |
SBC Key Ratios
SBC Medical Group Holdings Incorporated (SBC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
Return on Equity (ROE) | 31.29% | 27.51% | 22.25% | 15.9% |
Return on Invested Capital (ROIC) | 77.99% | 72.31% | 43.38% | 34.47% |
Gross Margin | 70.94% | 75.97% | 73.32% | 70.2% |
Net Margin | 20.34% | 22.69% | 29.37% | 24.09% |
Debt / Equity | 0.16x | 0.06x | 0.20x | 0.08x |
Interest Coverage | 1625.55x | 2596.61x | 512.05x | 254.43x |
FCF Conversion | 1.29x | 0.44x | 0.76x | 1.08x |
Revenue Growth | 11.13% | 6.13% | -15.48% | -14.45% |
Related:SBC Dividend History·SBC Revenue History·SBC Price History·SBC P/E History·SBC Financial Ratios·SBC Institutional Holders
SBC SEC Filings & Documents
SBC Medical Group Holdings Incorporated (SBC) SEC filings — annual & quarterly reports (10-K, 10-Q)
SBC Frequently Asked Questions
SBC Medical Group Holdings Incorporated (SBC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
SBC Medical Group Holdings Incorporated (SBC) reported $169.3M in revenue for fiscal year 2025. This represents a 3% decrease from $174.2M in 2022.
SBC Medical Group Holdings Incorporated (SBC) saw revenue decline by 15.5% over the past year.
Yes, SBC Medical Group Holdings Incorporated (SBC) is profitable, generating $40.8M in net income for fiscal year 2025 (29.4% net margin).
Dividend & Returns
SBC Medical Group Holdings Incorporated (SBC) has a return on equity (ROE) of 22.2%. This is excellent, indicating efficient use of shareholder capital.
SBC Medical Group Holdings Incorporated (SBC) generated $44.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.